InnovAge
INNV
#5394
Rank
A$2.25 B
Marketcap
A$16.62
Share price
-1.12%
Change (1 day)
155.07%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2025 (TTM): A$6.46 Million

According to InnovAge's latest financial reports the company's current earnings are A$0.91 Billion. , an increase over its 2024 earnings that were of -A$37.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2025

Annual earnings

Year Earnings Change
2025 A$7.36 M-119.56%
2024 -A$37.67 Million-24.58%
2023 -A$49.95 Million-31.82%
2022 -A$73.26 Million-681.94%
2021 A$12.58 M-388.91%
2020 -A$4.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$18.96 B 257,328.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-A$14.09 Million-291.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$14.84 Million-301.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
A$0.73 B 9,932.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland